HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China
· Delayed Price · Currency is CNY 3.360
+0.030 (0.90%)
At close: Mar 10, 2026
SHE:002437 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,500 | 5,677 | 5,517 | 5,583 | 6,397 | 7,034 | Upgrade
|
| Market Cap Growth | 27.51% | 2.89% | -1.18% | -12.72% | -9.06% | 5.61% | Upgrade
|
| Enterprise Value | 6,763 | 5,277 | 5,430 | 5,794 | 6,481 | 7,718 | Upgrade
|
| Last Close Price | 3.36 | 2.49 | 2.51 | 2.54 | 2.91 | 3.20 | Upgrade
|
| PE Ratio | 26.40 | 24.39 | 45.85 | - | 142.01 | 17.58 | Upgrade
|
| Forward PE | 30.55 | 24.55 | 24.55 | 24.55 | 24.55 | 24.55 | Upgrade
|
| PS Ratio | 3.34 | 2.33 | 2.10 | 1.80 | 2.03 | 2.30 | Upgrade
|
| PB Ratio | 3.44 | 2.88 | 3.23 | 3.28 | 3.23 | 3.64 | Upgrade
|
| P/TBV Ratio | 4.64 | 4.01 | 5.01 | 5.36 | 5.36 | 6.48 | Upgrade
|
| P/FCF Ratio | 20.16 | 16.31 | 22.56 | 24.42 | 26.69 | - | Upgrade
|
| P/OCF Ratio | 17.91 | 13.81 | 20.12 | 21.34 | 23.33 | 551.09 | Upgrade
|
| EV/Sales Ratio | 3.01 | 2.16 | 2.07 | 1.86 | 2.06 | 2.53 | Upgrade
|
| EV/EBITDA Ratio | - | 16.04 | 19.71 | 26.87 | 25.45 | 1727.71 | Upgrade
|
| EV/EBIT Ratio | 33.26 | 23.42 | 31.58 | 67.68 | 56.03 | - | Upgrade
|
| EV/FCF Ratio | 18.18 | 15.16 | 22.20 | 25.35 | 27.04 | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.00 | 0.40 | 0.85 | 0.79 | 0.70 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.01 | 2.45 | 6.75 | 5.99 | 302.75 | Upgrade
|
| Debt / FCF Ratio | 0.20 | 0.01 | 2.76 | 6.37 | 6.50 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.35 | -0.26 | -0.02 | 0.10 | 0.03 | 0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | - | -1.55 | -0.13 | 0.77 | 0.25 | 102.30 | Upgrade
|
| Net Debt / FCF Ratio | -2.04 | -1.46 | -0.15 | 0.73 | 0.26 | -14.79 | Upgrade
|
| Asset Turnover | 0.77 | 0.82 | 0.73 | 0.71 | 0.68 | 0.56 | Upgrade
|
| Inventory Turnover | 6.82 | 6.00 | 5.42 | 4.81 | 2.30 | 2.06 | Upgrade
|
| Quick Ratio | 1.17 | 0.80 | 0.67 | 0.67 | 0.68 | 0.53 | Upgrade
|
| Current Ratio | 1.39 | 1.07 | 0.82 | 0.78 | 0.82 | 0.70 | Upgrade
|
| Return on Equity (ROE) | 14.60% | 13.17% | 7.54% | -15.72% | 2.75% | 23.21% | Upgrade
|
| Return on Assets (ROA) | 4.34% | 4.71% | 2.97% | 1.22% | 1.57% | -1.66% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.62% | 12.27% | 7.06% | 4.38% | 3.27% | -3.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.20% | 11.30% | 9.90% | 4.90% | 5.70% | -7.30% | Upgrade
|
| Earnings Yield | 3.91% | 4.10% | 2.18% | -5.22% | 0.70% | 5.69% | Upgrade
|
| FCF Yield | 4.96% | 6.13% | 4.43% | 4.09% | 3.75% | -0.44% | Upgrade
|
| Payout Ratio | - | 4.02% | 36.41% | - | 157.49% | 33.62% | Upgrade
|
| Buyback Yield / Dilution | -4.69% | -2.82% | -0.05% | -0.07% | 0.04% | 0.01% | Upgrade
|
| Total Shareholder Return | -4.69% | -2.82% | -0.05% | -0.07% | 0.04% | 0.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.